Comparative effect of curcumin and nanocurcumin on nephroprotection at cisplatin-induced rats
Background: Cisplatin is a first-line chemotherapeutic agent for various solid tumors including ovarian and breast cancer. Thereby, it has been proven effective as an antineoplastic agent, but its clinically use is limited because of its nephrotoxicity side effect. Aims and Objectives: This study ai...
Saved in:
Main Authors: | Ni Made D Sandhiutami (Author), Wawaimuli Arozal (Author), Melva Louisa (Author), Deni Rahmat (Author), Tjoeng Mandy (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanocurcumin preserves kidney function and haematology parameters in DMBA-induced ovarian cancer treated with cisplatin via its antioxidative and anti-inflammatory effect in rats
by: Melva Louisa, et al.
Published: (2023) -
Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA
by: Ni Made Dwi Sandhiutami, et al.
Published: (2021) -
Development, Characterization and Pharmacokinetic Profile of Chitosan-Sodium Tripolyphosphate Nanoparticles Based Drug Delivery Systems for Curcumin
by: Wawaimuli Arozal, et al.
Published: (2021) -
Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration
by: Agian Jeffilano Barinda, et al.
Published: (2022) -
Utilization of curcumine and nanocurcumine compounds in cancer therapy
by: Vajiheh Alinezhad, et al.
Published: (2017)